BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8930405)

  • 1. Expression of neurofibromatosis 2 transcript and gene product during mouse fetal development.
    Huynh DP; Tran TM; Nechiporuk T; Pulst SM
    Cell Growth Differ; 1996 Nov; 7(11):1551-61. PubMed ID: 8930405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the neurofibromatosis 2 gene promoter expression during embryonic development.
    Akhmametyeva EM; Mihaylova MM; Luo H; Kharzai S; Welling DB; Chang LS
    Dev Dyn; 2006 Oct; 235(10):2771-85. PubMed ID: 16894610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurofibromatosis type 2 (NF2)].
    Araki N; Takeshima H; Saya H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of chicken Nf2/merlin indicates regulatory roles in cell proliferation and migration.
    Chen Y; Gutmann DH; Haipek CA; Martinsen BJ; Bronner-Fraser M; Krull CE
    Dev Dyn; 2004 Mar; 229(3):541-54. PubMed ID: 14991710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells.
    Huynh DP; Pulst SM
    Oncogene; 1996 Jul; 13(1):73-84. PubMed ID: 8700556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types.
    Bianchi AB; Hara T; Ramesh V; Gao J; Klein-Szanto AJ; Morin F; Menon AG; Trofatter JA; Gusella JF; Seizinger BR
    Nat Genet; 1994 Feb; 6(2):185-92. PubMed ID: 8162073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells.
    Lutchman M; Rouleau GA
    Cancer Res; 1995 Jun; 55(11):2270-4. PubMed ID: 7757975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF2: the wizardry of merlin.
    Xiao GH; Chernoff J; Testa JR
    Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin.
    Scoles DR; Huynh DP; Morcos PA; Coulsell ER; Robinson NG; Tamanoi F; Pulst SM
    Nat Genet; 1998 Apr; 18(4):354-9. PubMed ID: 9537418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression pattern of BM88 in the developing nervous system of the chick and mouse embryo.
    Politis PK; Rohrer H; Matsas R
    Gene Expr Patterns; 2007 Jan; 7(1-2):165-77. PubMed ID: 16949349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
    Koga H; Araki N; Takeshima H; Nishi T; Hirota T; Kimura Y; Nakao M; Saya H
    Oncogene; 1998 Aug; 17(7):801-10. PubMed ID: 9779996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative transcripts in the mouse neurofibromatosis type 2 (NF2) gene are conserved and code for schwannomins with distinct C-terminal domains.
    Huynh DP; Nechiporuk T; Pulst SM
    Hum Mol Genet; 1994 Jul; 3(7):1075-9. PubMed ID: 7981675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interdomain binding mediates tumor growth suppression by the NF2 gene product.
    Sherman L; Xu HM; Geist RT; Saporito-Irwin S; Howells N; Ponta H; Herrlich P; Gutmann DH
    Oncogene; 1997 Nov; 15(20):2505-9. PubMed ID: 9395247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumour suppressor protein NF2/merlin: the puzzle continues.
    Hovens CM; Kaye AH
    J Clin Neurosci; 2001 Jan; 8(1):4-7. PubMed ID: 11148074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deposition of collagen VI in the extracellular matrix during mouse embryogenesis correlates with expression of the alpha 3(VI) subunit gene.
    Dziadek M; Darling P; Bakker M; Overall M; Zhang RZ; Pan TC; Tillet E; Timpl R; Chu ML
    Exp Cell Res; 1996 Aug; 226(2):302-15. PubMed ID: 8806434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
    Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
    Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurofibromatosis 2 (NF2) tumour suppressor gene: implications beyond the hereditary tumour syndrome?
    Kley N; Seizinger BR
    Cancer Surv; 1995; 25():207-18. PubMed ID: 8718520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the neurofibromatosis 2 gene in human breast and hepatocellular carcinomas.
    Kanai Y; Tsuda H; Oda T; Sakamoto M; Hirohashi S
    Jpn J Clin Oncol; 1995 Feb; 25(1):1-4. PubMed ID: 7877257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A point mutation associated with a severe phenotype of neurofibromatosis 2.
    MacCollin M; Braverman N; Viskochil D; Ruttledge M; Davis K; Ojemann R; Gusella J; Parry DM
    Ann Neurol; 1996 Sep; 40(3):440-5. PubMed ID: 8797533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of NF2-encoded merlin and related ERM family proteins in the human central nervous system.
    Stemmer-Rachamimov AO; Gonzalez-Agosti C; Xu L; Burwick JA; Beauchamp R; Pinney D; Louis DN; Ramesh V
    J Neuropathol Exp Neurol; 1997 Jun; 56(6):735-42. PubMed ID: 9184664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.